abstract |
The present invention provides lipid-based nanoparticles (e.g., liposomes or exosomes) comprising CD47 on the surface and comprising a therapeutic agent (e.g., therapeutic protein, antibody, inhibitory RNA, and / or small molecule drug) to provide. The present invention is also provided for use of such lipid-based nanoparticles in therapy. |